- Home
- NMRA vs ECF Comparison
NMRA vs ECF Comparison
Compare NMRA & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- ECF
- Stock Information
- Founded
- NMRA 2019
- ECF 1986
- Country
- NMRA United States
- ECF United States
- Employees
- NMRA N/A
- ECF N/A
- Industry
- NMRA
- ECF Finance/Investors Services
- Sector
- NMRA
- ECF Finance
- Exchange
- NMRA Nasdaq
- ECF Nasdaq
- Market Cap
- NMRA 121.0M
- ECF 118.6M
- IPO Year
- NMRA 2023
- ECF N/A
- Fundamental
- Price
- NMRA $0.77
- ECF $9.95
- Analyst Decision
- NMRA Buy
- ECF
- Analyst Count
- NMRA 8
- ECF 0
- Target Price
- NMRA $9.29
- ECF N/A
- AVG Volume (30 Days)
- NMRA 820.4K
- ECF 57.7K
- Earning Date
- NMRA 08-05-2025
- ECF 01-01-0001
- Dividend Yield
- NMRA N/A
- ECF 6.42%
- EPS Growth
- NMRA N/A
- ECF N/A
- EPS
- NMRA N/A
- ECF 0.46
- Revenue
- NMRA N/A
- ECF N/A
- Revenue This Year
- NMRA N/A
- ECF N/A
- Revenue Next Year
- NMRA N/A
- ECF N/A
- P/E Ratio
- NMRA N/A
- ECF $17.61
- Revenue Growth
- NMRA N/A
- ECF N/A
- 52 Week Low
- NMRA $0.61
- ECF $7.02
- 52 Week High
- NMRA $17.19
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- NMRA 45.74
- ECF 54.99
- Support Level
- NMRA $0.81
- ECF $9.58
- Resistance Level
- NMRA $1.34
- ECF $10.08
- Average True Range (ATR)
- NMRA 0.10
- ECF 0.13
- MACD
- NMRA -0.01
- ECF -0.03
- Stochastic Oscillator
- NMRA 12.55
- ECF 49.18
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.